Tenderwize
Back to tender search

Open-house rebate agreement for Anakinra

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Aug 03, 2027 · 352 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Anakinra, ATC L04AC03

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

The notice explicitly says the contract documents must be submitted through the communication area in the DTVP portal a...

Only pharmaceutical companies are eligible as potential contract partners, and suitability must be proven by a signed d...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Non-exclusive rebate agreements for the active substance Anakinra, ATC L04AC03.
  • Open-house model with identical, non-negotiable contract terms for all eligible pharmaceutical companies.
Show full summary

Open-house supply arrangement for pharmaceutical products: non-exclusive rebate agreements for Anakinra (ATC L04AC03) offered by AOK Bayern to all interested pharmaceutical companies meeting the stated suitability requirement. This is explicitly described as an open-house model, not a competitive award procedure, with identical non-negotiable contract terms and no selection among bidders. Contracting is possible during the term, with the earliest start on 2025-10-01 and latest contract conclusion by 2027-08-03. Submission can be paper or electronic via DTVP, but the contract documents must be submitted through the communication area, not the offer area.

Risks

The notice explicitly says the contract documents must be submitted through the communication area in the DTVP portal a...

Only pharmaceutical companies are eligible as potential contract partners, and suitability must be proven by a signed d...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
  • The contract must be submitted signed; signatory authority must be evidenced by the commercial register extract or a power of attorney must be provided.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Anakinra

Single lot for non-exclusive pharmaceutical rebate agreements concerning Anakinra, ATC L04AC03. Scope is pharmaceutical supplies under an open-house model; contract terms are pre-set and not individually negotiable. The lot is for Germany, with performance in Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Aug 03, 2027

Procurement Details

Publication date
13 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
532705-2025

Documents (2)

Similar tenders